Huoleti Oy and Roche Oy have signed a co-operation agreement
Following the agreement, Roche Oy will participate in Huoleti’s marketing efforts by boosting awareness of the company’s application and service among health care professionals and patient organisations. The first phase of the agreement extends until the end of 2019.
“This co-operation with the world’s largest cancer company offers us brand new channels and opportunities in Finland,” says Maria Lipsonen, COO of Huoleti Oy.
“Roche Oy wishes to support patients during their treatment and recovery,” explains Anssi Linnankivi, Medical Director at Roche Oy. “Huoleti-service offers patients everyday assistance in a novel and innovative way, and we are pleased to help implementing it.”
Read the entire article here.